Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells.
Trefoil factors (TFFs) are protease-resistant peptides that promote epithelial cell migration and mucosal restitution during inflammatory conditions and wound healing in the gastrointestinal tract. To date, the molecular mechanism of TFFs action and their possible role in tumor progression are unclear. In the present study, we observed that premalignant human colonic PC/AA/C1 and canine kidney MDCK epithelial cells are not competent to invade collagen gels in response to exogenously added TFFs (pS2, spasmolytic polypeptide, and intestinal trefoil factor). In contrast, activated src and RhoA exert permissive induction of invasion by the TFFs that produce similar parallel dose-response curves in src-transformed MDCKts.src and PCmsrc cells (EC50=20-40 nM). Cell scattering is also induced by TFFs in MDCKts.src cells. Stable expression of the pS2 cDNA promotes constitutive invasiveness in MDCKts.src-pS2 cells and human colonic HCT8/S11-pS2 cells established from a sporadic tumor. Furthermore, we found that TFF-mediated cellular invasion is dependent of several signaling pathways implicated in cell transformation and survival, including phosphoinositide PI3'-kinase, phospholipase C, protein kinase C, and the rapamycin target TOR. Constitutive and intense expression of pS2 was revealed by Western blot analyses and immunohistochemistry in human colorectal tumors and their adjacent control mucosa during the neoplastic progression, from the adenoma to the liver metastases. Our studies indicated that TFFs can be involved in cell scattering and tumor invasion via autocrine loops and may serve as potential targets in the control of colon cancer progression.
Emami
S
S
INSERM U482, Signal Transduction and Cellular Functions in Diabetes and Digestive Cancers, Hôpital Saint-Antoine, 75571 Paris Cedex 12, France.
Le Floch
N
N
Bruyneel
E
E
Thim
L
L
May
F
F
Westley
B
B
Rio
M
M
Mareel
M
M
Gespach
C
C
D000818:Animals; D002461:Cell Line, Transformed; D002465:Cell Movement; D003094:Collagen; D003110:Colonic Neoplasms; D015179:Colorectal Neoplasms / Q000473:pathology*; D004285:Dogs; D004791:Enzyme Inhibitors / Q000494:pharmacology; D016391:Genes, src; D006133:Growth Substances / Q000494:pharmacology*; D006801:Humans; D007413:Intestinal Mucosa / Q000473:pathology / Q000503:physiopathology; D007668:Kidney; D009077:Mucins; D009124:Muscle Proteins; D009361:Neoplasm Invasiveness; D009479:Neuropeptides; D010455:Peptides / Q000494:pharmacology*; D011230:Precancerous Conditions; D011994:Recombinant Proteins / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D000071164:Trefoil Factor-2; D000071165:Trefoil Factor-3; D019459:Urothelium; D020742:rhoA GTP-Binding Protein / Q000235:genetics / Q000502:physiology*
D004791:Enzyme Inhibitors; D006133:Growth Substances; D009077:Mucins; D009124:Muscle Proteins; D009479:Neuropeptides; D010455:Peptides; D011994:Recombinant Proteins; C099037:TFF3 protein, rat; C000604008:Tff2 protein, rat; D000071164:Trefoil Factor-2; D000071165:Trefoil Factor-3; D003094:Collagen; D020742:rhoA GTP-Binding Protein